ADHD Treatment Guidelines

Introduction to Treatment

The American Academy of Pediatrics recommends a standard approach for both children and adults with ADHD, combining FDA-approved medications with behavioral interventions, with specific recommendations based on age group 1

The American Academy of Pediatrics suggests FDA-approved medications, particularly methylphenidate, as a first-line treatment for ADHD 1
Stimulant medications have stronger immediate effects on core ADHD symptoms 2

Starting doses and maximum daily doses for stimulant medications are recommended as follows:

Medication	Starting Dose	Maximum Daily Dose
Methylphenidate	5 mg twice daily for immediate-release and 10 mg once daily for extended-release	up to 1.0 mg/kg per day
Amphetamine	5-10 mg daily	up to 50 mg daily
Adderall	5-10 mg daily	up to 50 mg daily

Common side effects include agitation, insomnia, and appetite suppression, as reported by the National Comprehensive Cancer Network 6
Less common side effects include hypertension, palpitations, arrhythmias, confusion, psychosis, tremor, and headache, according to the National Comprehensive Cancer Network 6
Contraindications include uncontrolled hypertension, coronary artery disease, and tachyarrhythmias, as stated by the National Comprehensive Cancer Network 6
Methylphenidate should be started at lower doses and increased in smaller increments, especially in younger children, due to slower metabolism in this age group, as recommended by the American Academy of Pediatrics 7
Extended-release guanfacine or clonidine can be used as non-stimulant options, or as adjunctive therapy, according to the American Academy of Pediatrics 1
Combination therapy with non-stimulants like atomoxetine and extended-release guanfacine is supported by sufficient evidence for improved symptom control, with an effect size of ~0.7 7, 1

Parent Training in Behavior Management (PTBM) and behavioral classroom interventions are recommended as part of a comprehensive treatment plan for ADHD, with an effect size of 0.55 for behavioral parent training and 0.61 for behavioral classroom management 1, 2
Educational interventions with individualized instructional supports can be beneficial for individuals with ADHD, and may require an Individualized Education Program (IEP) or 504 plan 1, 2
Classroom behavioral interventions should be coordinated with the school, as recommended by the American Academy of Pediatrics 1
Concurrent behavioral interventions (PTBM and/or classroom interventions) are recommended in addition to medication 1, 7

A healthy diet pattern that emphasizes fruits, vegetables, whole grains, and low-fat dairy products is recommended, with a strength of evidence based on observational studies and expert consensus, and sodium intake should be limited to 6 g/day to minimize the risk of cardiovascular side effects, with a moderate strength of evidence based on clinical trials and observational studies 8
Regular physical activity (≥150 minutes/week) combining aerobic and resistance exercise is recommended, as it improves executive functioning and reduces core ADHD symptoms, and can help reduce anxiety and improve mood regulation, as suggested by the European Society of Cardiology 9

For children and adolescents, a combination of FDA-approved medications with behavioral interventions (PTBM and/or classroom interventions) is most effective in managing ADHD symptoms 1, 2
Family preference is essential in determining the treatment plan and enhancing adherence to treatment 1, 2
Growth parameters should be monitored regularly, as stimulants can affect growth velocity, according to the American Academy of Pediatrics 7
Medication dosage should be adjusted based on weight changes as the child grows, as recommended by the American Academy of Pediatrics 7
Regular monitoring every 3-4 weeks during dose titration and once stabilized, follow-up every 3-6 months, with parameters such as appetite, weight, sleep disturbances, mood changes, and growth parameters monitored regularly, as recommended by the American Academy of Pediatrics 7, 10, 11, 12

Comorbid conditions, such as anxiety or depression, should be assessed and treated, as recommended by the American Academy of Pediatrics 1
For patients with comorbid bipolar disorder and ADHD, it is recommended to stabilize mood symptoms with mood stabilizers before considering low-dose stimulants for residual ADHD symptoms, as per the American Academy of Child and Adolescent Psychiatry guidelines 13
Electronic prescribing systems for controlled substances, including those for ADHD, must meet DEA requirements for authentication, security, and record-keeping, including two-factor authentication for prescribers when sending electronic prescriptions, as recommended by the DEA, and the electronic system must be certified for EPCS compliance to ensure the strict controls necessary for Schedule II medications, such as stimulants used in ADHD treatment, as required by regulatory standards 10